26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: Update on clinical research

Breast Cancer Research

Volumn 6, Issue 2, 2004, Pages 84-87

  Kramer, Rita ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Chemotherapy; Clinical research; Hormone therapy; Meeting report

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; LETROZOLE; PACLITAXEL; PLACEBO; PREDNISOLONE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RECURRENCE; CANCER RESEARCH; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CYTOLOGY; DRUG EFFICACY; DRUG POTENTIATION; DRUG TARGETING; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HORMONAL THERAPY; HOT FLUSH; HUMAN; MASTECTOMY; MOLECULAR BIOLOGY; MYALGIA; POSTMENOPAUSE; SYMPOSIUM; TREATMENT PLANNING; UNITED STATES; VAGINA BLEEDING;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HORMONES; HUMANS; RADIOTHERAPY; TEXAS;

EID: 1542346153     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr761     Document Type: Conference Paper

References (6)

1. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard K, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Therasse P, Palmer MJ, Pater JL: A randomized trial of letrozole in postmenopausal women after five years of tamoxifien therapy for early-state breast cancer. N Engl J Med 2003, 349:1793-1802.
2. Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T, Group TAT: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet 2002, 359:2131-2139.
3. Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 2003, 98:1802-1810.
4. Hutcheson AW, Heys SD, Sarkar TK, Aberdeen Breast Group A, Scotland: Neoadjuvant docetaxel in locally advanced breast cancer. Breast Cancer Res Treat 2003, 79(Suppl):S19-S24.
5. Nabholtz J, Pienlowski T, Mackey J, Pawlicki M, Guastalla J, Vogel C, Weaver C, Walley B, Martin M, Chap L, Tomiak E, Juhos E, Guevin R, Howell A, Hainsworth J, Fornander T, Blitz S, Gazel S, Loret C, Riva A: Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients: Interim analysis of the BCIRG 001 study [abstract]. ProASCO 2002, 21:36a.
6. Vaidya J, Joseph D, Hilaris B, Tobias J, Houghton J, D'Souza D, Sainsbury R, Keshtgar M, Sainsbury R, Taylor I, Baum M: Targeted intraoperative radiotherapy (TARGIT) for breast cancer: An international trial [abstract 452]. Breast Cancer Res Treat 2002, 76(Suppl 1):S116.